Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

With CBD Products Unlawful, FDA Enforcement Policy Guidance Has No Economic Significance

Aug 08 2020

• By Malcolm Spicer

CBD Cannabidiol Marijuana Cannabis Map Pins Store Locations

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

Related Content

A Year After US FDA Public Hearing: CBD Demand Soars Along With Need For Safety Data

Jun 16 2020

US FDA Reopens Door For CBD Safety Data, But NPA Says Window Closing For Setting Safe Level

Mar 10 2020

US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development

Jul 10 2020

Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking

Aug 04 2020

FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements

Dec 28 2018

Additional Topics

International United States US States Cannabidiol CBD Guidance Documents Dietary Supplements Advertising, Marketing & Sales Business Strategies Compliance Commercial FDA Ingredients Enforcement Manufacturing Policy Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window